Skip to main content

Table 2 General features of the studies

From: Adverse drug events observed with intrathecal magnesium sulfate as an adjuvant to bupivacaine for spinal anesthesia in patients undergoing elective cesarean section: a meta-analysis

Studies

Type of study

Enrollment time period

No of participants assigned to MgSO4 group (n)

No of participants assigned to the control group (n)

Elsharkawy 2018 [12]

Prospective randomized double blind study

-

30

30

Faiz 2013 [13]

Randomized double blind controlled study

2011 – 2012

36

36

Jabalameli 2012 [14]

Prospective doubled blind randomized trial

2010 – 2011

69

33

Malleeswaran 2010 [15]

Randomized study

-

30

30

Paleti 2018 [16]

Randomized clinical trial

2015

25

25

Sachidananda 2018 [17]

Placebo controlled randomized double-blind pilot study

-

41

40

Sun 2012 [18]

Prospective randomized double blind study

-

100

100

Unlugenc 2009 [19]

Prospective, randomized, double blind study

-

30

30

Xiao 2017 [20]

Prospective, double blinded, randomized, dose response trial

2014

30

30

Yousef 2010 [21]

Prospective double blind randomized trial

-

45

45

Zhong 2018 [22]

Randomized clinical trial

2015

30

30

TOTAL no of participants (n)

  

466

429

  1. Table 2 lists the general properties of the original studies which have been included in this analysis. This includes the type of study, the year of participants’ enrollment, and the number of participants in the experiment and the control group
  2. Abbreviations MgSO4: Magnesium sulfate